The startup develops precision diagnostics technology that enhances benchtop scale sequencers for liquid biopsies, enabling efficient detection of oncology and infectious diseases. By removing barriers to global access, the company increases the availability of molecular diagnostic tests for healthcare professionals.

Marginum develops tissue recognition technology specifically for oncological surgery to improve patient outcomes. Their solution enables precise, non-invasive detection of cancerous tissue during procedures, minimizing damage to healthy structures. This technology assists surgeons by providing safe and efficient tissue monitoring without disrupting established surgical workflows.

MONCYTE Health provides a laboratory‑based diagnostic test that quantifies lipid uptake and storage in monocytes to predict individual responses to cholesterol‑lowering therapy. By integrating this cellular analysis with risk assessment, the test helps cardiologists and primary‑care physicians identify patients who will not reach LDL‑C, Lp(a) or triglyceride targets with statins alone and recommends more effective combination treatments, reducing residual cardiovascular risk.

Pictor Labs offers an AI‑driven virtual staining platform that converts label‑free autofluorescence images of tissue slides into diagnostic‑quality stains such as H&E and IHC within minutes. By eliminating chemical reagents, the technology preserves the original sample for multiple downstream tests and integrates with existing slide scanners via on‑premise or cloud deployment.

Pod is a fintech platform that facilitates secure fundraising for early-stage Indian startups by enabling retail investors to access private equity opportunities previously limited to high-net-worth individuals and venture capitalists. The platform offers a streamlined investment process with a smart dashboard for real-time performance tracking, allowing users to diversify their portfolios with micro ticket sizes across vetted startups.